Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 41, first published in 1977, and continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs, presents clinicians and medical investigators with a critical survey of new data and trends in adverse drug reactions and interactions. Topics covered in this new release include Central Nervous System Stimulants and Drugs that Suppress Appetite, Antidepressants, Lithium, Drugs of Abuse, Hypnotics and Sedatives, Antipsychotic Drugs, Antiepileptics, Opioid Analgesics and Narcotic Antagonists, Anti-Inflammatory and Antipyretic Analgesics and Drugs Used in Gout, and much more.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. v 6. Preface - p. xvii 7. Special Reviews in SEDA 41 - p. xix 8. Table of Essays, Annuals 1–40 - p. xxi 9. Abbreviations - p. xxiii 10. ADRs, ADEs and SEDs: A bird's eye view - p. pgxxvii 11. Chapter 1: Central nervous system stimulants and drugs that suppress appetite - p. pgxlviii 12. Chapter 2: Antidepressants - p. 11 13. Chapter 3: Lithium - p. 26 14. Chapter 4: Drugs of abuse - p. 31 15. Chapter 5: Sedatives and hypnotics - p. 41 16. Chapter 6: Antipsychotic agents - p. 49 17. Chapter 7: Anti-epileptic medications - p. 63 18. Chapter 8: Opioid analgesics and narcotic antagonists - p. 96 19. Chapter 9: Anti-inflammatory and antipyretic analgesics and drugs used in gout - p. 102 20. Chapter 10: General anesthetics and therapeutic gases - p. 114 21. Chapter 11: Local anesthetics - p. 131 22. Chapter 12: Neuromuscular blocking agents and skeletal muscle relaxants - p. 138 23. Chapter 13: Drugs that affect autonomic functions or the extrapyramidal system - p. 150 24. Chapter 14: Antihistamines (H1 receptor antagonists) - p. 161 25. Chapter 15: Drugs that act on the respiratory tract - p. 170 26. Chapter 16: Positive inotropic drugs and drugs used in dysrhythmias - p. 182 27. Chapter 17: Beta adrenergic antagonists and antianginal drugs - p. 195 28. Chapter 18: Drugs acting on the cerebral and peripheral circulations - p. 205 29. Chapter 19: Antihypertensive drugs - p. 217 30. Chapter 20: Diuretics - p. 225 31. Chapter 21: Metals and metal antagonists - p. 236 32. Chapter 22: Antiseptic drugs and disinfectants - p. 249 33. Chapter 23: Beta-lactams and tetracyclines - p. 256 34. Chapter 24: Miscellaneous antibacterial drugs - p. 267 35. Chapter 25: Antifungal drugs - p. 284 36. Chapter 26: Antiprotozoal drugs - p. 292 37. Chapter 27: Antiviral drugs - p. 300 38. Chapter 28: Drugs in tuberculosis and leprosy - p. 319 39. Chapter 29: Antihelminthic drugs - p. 338 40. Chapter 30: Vaccines - p. 349 41. Chapter 31: Blood, blood components, plasma, and plasma products - p. 372 42. Chapter 32: Vitamins, amino acids, and drugs and formulations used in nutrition - p. 386 43. Chapter 33: Drugs that affect blood coagulation, fibrinolysis and hemostasis - p. 400 44. Chapter 34: Gastrointestinal drugs - p. 406 45. Chapter 35: Drugs that act on the immune system: Cytokines and monoclonal antibodies - p. 421 46. Chapter 36: Drugs that act on the immune system: Immunosuppressive and immunostimulatory drugs - p. 433 47. Chapter 37: Corticotrophins, corticosteroids, and prostaglandins - p. 459 48. Chapter 38: Sex hormones, related compounds and hormonal contraceptives including miscellaneous hormones - p. 470 49. Chapter 39: Thyroid hormones, iodine and iodides, and antithyroid drugs - p. 480 50. Chapter 40: Insulin and other hypoglycemic drugs - p. 492 51. Chapter 41: Adverse drug reactions and adverse drug events associated with use of psychotropic, antiepileptic, antihypertensive and antidiabetic drugs in pregnancy - p. 504 52. Chapter 42: Drugs that affect lipid metabolism - p. 517 53. Chapter 43: Radiological contrast agents and radiopharmaceuticals - p. 530 54. Chapter 44: Drugs used in ocular treatment - p. 547 55. Chapter 45: Safety of complementary and alternative medicine treatments and practices - p. 558 56. Chapter 46: Misc. medical devices and technologies - p. 571 57. Reviewers - p. 617 58. Index of Drugs - p. 619 59. Index of Drug-Drug Interactions - p. 627 60. Index of Adverse Effects and Adverse Reactions - p. 631
Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 41, first published in 1977, and continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs, presents clinicians and medical investigators with a critical survey of new data and trends in adverse drug reactions and interactions. Topics covered in this new release include Central Nervous System Stimulants and Drugs that Suppress Appetite, Antidepressants, Lithium, Drugs of Abuse, Hypnotics and Sedatives, Antipsychotic Drugs, Antiepileptics, Opioid Analgesics and Narcotic Antagonists, Anti-Inflammatory and Antipyretic Analgesics and Drugs Used in Gout, and much more.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. v 6. Preface - p. xvii 7. Special Reviews in SEDA 41 - p. xix 8. Table of Essays, Annuals 1–40 - p. xxi 9. Abbreviations - p. xxiii 10. ADRs, ADEs and SEDs: A bird's eye view - p. pgxxvii 11. Chapter 1: Central nervous system stimulants and drugs that suppress appetite - p. pgxlviii 12. Chapter 2: Antidepressants - p. 11 13. Chapter 3: Lithium - p. 26 14. Chapter 4: Drugs of abuse - p. 31 15. Chapter 5: Sedatives and hypnotics - p. 41 16. Chapter 6: Antipsychotic agents - p. 49 17. Chapter 7: Anti-epileptic medications - p. 63 18. Chapter 8: Opioid analgesics and narcotic antagonists - p. 96 19. Chapter 9: Anti-inflammatory and antipyretic analgesics and drugs used in gout - p. 102 20. Chapter 10: General anesthetics and therapeutic gases - p. 114 21. Chapter 11: Local anesthetics - p. 131 22. Chapter 12: Neuromuscular blocking agents and skeletal muscle relaxants - p. 138 23. Chapter 13: Drugs that affect autonomic functions or the extrapyramidal system - p. 150 24. Chapter 14: Antihistamines (H1 receptor antagonists) - p. 161 25. Chapter 15: Drugs that act on the respiratory tract - p. 170 26. Chapter 16: Positive inotropic drugs and drugs used in dysrhythmias - p. 182 27. Chapter 17: Beta adrenergic antagonists and antianginal drugs - p. 195 28. Chapter 18: Drugs acting on the cerebral and peripheral circulations - p. 205 29. Chapter 19: Antihypertensive drugs - p. 217 30. Chapter 20: Diuretics - p. 225 31. Chapter 21: Metals and metal antagonists - p. 236 32. Chapter 22: Antiseptic drugs and disinfectants - p. 249 33. Chapter 23: Beta-lactams and tetracyclines - p. 256 34. Chapter 24: Miscellaneous antibacterial drugs - p. 267 35. Chapter 25: Antifungal drugs - p. 284 36. Chapter 26: Antiprotozoal drugs - p. 292 37. Chapter 27: Antiviral drugs - p. 300 38. Chapter 28: Drugs in tuberculosis and leprosy - p. 319 39. Chapter 29: Antihelminthic drugs - p. 338 40. Chapter 30: Vaccines - p. 349 41. Chapter 31: Blood, blood components, plasma, and plasma products - p. 372 42. Chapter 32: Vitamins, amino acids, and drugs and formulations used in nutrition - p. 386 43. Chapter 33: Drugs that affect blood coagulation, fibrinolysis and hemostasis - p. 400 44. Chapter 34: Gastrointestinal drugs - p. 406 45. Chapter 35: Drugs that act on the immune system: Cytokines and monoclonal antibodies - p. 421 46. Chapter 36: Drugs that act on the immune system: Immunosuppressive and immunostimulatory drugs - p. 433 47. Chapter 37: Corticotrophins, corticosteroids, and prostaglandins - p. 459 48. Chapter 38: Sex hormones, related compounds and hormonal contraceptives including miscellaneous hormones - p. 470 49. Chapter 39: Thyroid hormones, iodine and iodides, and antithyroid drugs - p. 480 50. Chapter 40: Insulin and other hypoglycemic drugs - p. 492 51. Chapter 41: Adverse drug reactions and adverse drug events associated with use of psychotropic, antiepileptic, antihypertensive and antidiabetic drugs in pregnancy - p. 504 52. Chapter 42: Drugs that affect lipid metabolism - p. 517 53. Chapter 43: Radiological contrast agents and radiopharmaceuticals - p. 530 54. Chapter 44: Drugs used in ocular treatment - p. 547 55. Chapter 45: Safety of complementary and alternative medicine treatments and practices - p. 558 56. Chapter 46: Misc. medical devices and technologies - p. 571 57. Reviewers - p. 617 58. Index of Drugs - p. 619 59. Index of Drug-Drug Interactions - p. 627 60. Index of Adverse Effects and Adverse Reactions - p. 631
